JULYE EATON: Open Payments
NPI 1679683221 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,548 in 149 payments from 15 companies in 2025. Trend: 2023 $2,085 · 2024 $1,876 · 2025 $2,548
Food & beverage: $2,347Education: $201
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $535 |
| Alkermes, Inc. | 18 | $317 |
| Otsuka America Pharmaceutical, Inc. | 19 | $314 |
| Janssen Pharmaceuticals, Inc | 19 | $257 |
| Vanda Pharmaceuticals Inc. | 16 | $240 |
| Neurocrine BioSciences, Inc. | 11 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $198 |
| Axsome Therapeutics, Inc. | 12 | $164 |
| Supernus Pharmaceuticals, Inc. | 4 | $65 |
| Noven Therapeutics, LLC | 4 | $61 |
Products named: REXULTI, ARISTADA, FANAPT, INVEGA SUSTENNA, INGREZZA, UZEDY, CAPLYTA, Auvelity.
Industry payments across OK — which companies pay providers there.
